Follow
GURCAN GUNAYDIN
Title
Cited by
Cited by
Year
Photodynamic therapy—current limitations and novel approaches
G Gunaydin, ME Gedik, S Ayan
Frontiers in Chemistry 9, 691697, 2021
2502021
A bifunctional photosensitizer for enhanced fractional photodynamic therapy: singlet oxygen generation in the presence and absence of light
IS Turan, D Yildiz, A Turksoy, G Gunaydin, EU Akkaya
Angewandte Chemie International Edition 55 (8), 2875-2878, 2016
2412016
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status
G Gunaydin, ME Gedik, S Ayan
Frontiers in Chemistry 9, 686303, 2021
2142021
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
B Gok Yavuz, G Gunaydin, ME Gedik, K Kosemehmetoglu, D Karakoc, ...
Scientific reports 9 (1), 3172, 2019
2112019
CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion
G Gunaydin
Frontiers in oncology 11, 668349, 2021
892021
Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset
G Gunaydin, SA Kesikli, D Guc
Oncoimmunology 4 (9), e1034918, 2015
562015
Molecular demultiplexer as a terminator automaton
IS Turan, G Gunaydin, S Ayan, EU Akkaya
Nature Communications 9 (1), 805, 2018
512018
Front Cover: Mitochondria‐Targeting Selenophene‐Modified BODIPY‐Based Photosensitizers for the Treatment of Hypoxic Cancer Cells (ChemMedChem 22/2019)
O Karaman, T Almammadov, M Emre Gedik, G Gunaydin, S Kolemen, ...
ChemMedChem 14 (22), 1878-1878, 2019
39*2019
Mitochondria‐Targeting Selenophene‐Modified BODIPY‐Based Photosensitizers for the Treatment of Hypoxic Cancer Cells
O Karaman, T Almammadov, M Emre Gedik, G Gunaydin, S Kolemen, ...
ChemMedChem 14 (22), 1879-1886, 2019
392019
Proof-of-principle for two-stage photodynamic therapy: hypoxia triggered release of singlet oxygen
S Ayan, G Gunaydin, N Yesilgul-Mehmetcik, ME Gedik, O Seven, ...
Chemical Communications 56 (94), 14793-14796, 2020
352020
Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma
Y Dolen, G Gunaydin, G Esendagli, D Guc
Cellular immunology 295 (1), 29-35, 2015
242015
Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy
EÖ Gündüz, ME Gedik, G Günaydın, E Okutan
ChemMedChem 17 (6), e202100693, 2022
192022
Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line
O Esim, ME Gedik, AL Dogan, G Gunaydin, C Hascicek
Journal of Drug Delivery Science and Technology 64, 102655, 2021
182021
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia
G Gunaydin, K Altundag
The American Surgeon 77 (9), 1272-1273, 2011
132011
Immunometabolism–The Role of Branched-Chain Amino Acids
B Yahsi, G Gunaydin
Frontiers in Immunology 13, 2022
122022
Activation induced cytidine deaminase: An old friend with new faces
G GÜNAYDIN
Frontiers in Immunology 13, 2022
122022
The effects of cancer‐associated fibroblasts obtained from atypical ductal hyperplasia on anti‐tumor immune responses
B Gok Yavuz, G Gunaydin, K Kosemehmetoglu, D Karakoc, F Ozgur, ...
The breast journal 24 (6), 1099-1101, 2018
102018
Cover Feature: Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy (ChemMedChem 6/2022)
EÖ Gündüz, ME Gedik, G Günaydın, E Okutan
ChemMedChem 17 (6), e202200117, 2022
62022
Effects of cellular energy homeostasis modulation through AMPK on regulation of protein translation and response to hypoxia
G Gunaydin, ME Gedik
Turkish Journal of Biochemistry 44 (5), 611-620, 2019
62019
BODIPY-GO Nanocomposites Decorated with Biocompatible Branched Ethylene glycol Moiety for Targeted PDT
E Öztürk, R Atajanov, ME Gedik, ET Eçik, G Günaydın, E Okutan
Dalton Transactions, 2023
52023
The system can't perform the operation now. Try again later.
Articles 1–20